Kelli Smith
Optometrist · Kansas City, MONPI 1811283914
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,459 of the $7,429 with a category attached, or 60.0%. 19 manufacturers reported payments, led by Johnson & Johnson Vision Care, Inc. at 49.4% of the total. Reporting peaked in 2022 at $3,072 and has fallen 70.7% since, to $900 in 2025. Among optometrist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $45.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$4K
- Sun Pharmaceutical Industries Inc.$792
- Oyster Point Pharma, Inc.$658
- Alcon$433
- Bausch & Lomb Americas Inc.$379
- Coopervision Inc.$358
- plus $1K from 13 others
What the payments were for
- Consulting fees$2,02527%
- Travel & lodging$90612%
- Food & beverage$4,45960%
- Gifts$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 31 | $3,671 |
| Sun Pharmaceutical Industries Inc. | 21 | $792 |
| Oyster Point Pharma, Inc. | 23 | $658 |
| Alcon | 18 | $433 |
| Bausch & Lomb Americas Inc. | 18 | $379 |
| Coopervision Inc. | 19 | $358 |
| ANI Pharmaceuticals, Inc. | 4 | $190 |
| AbbVie | 3 | $164 |
| Sight Sciences, Inc. | 1 | $145 |
| Novartis | 2 | $139 |
| Mallinckrodt Hospital Products Inc. | 6 | $134 |
| Tarsus Pharmaceuticals, Inc. | 4 | $112 |
| Glaukos Corporation | 3 | $60 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $58 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Biotissue Holdings Inc. | 2 | $36 |
| Thea Pharma Inc. | 1 | $23 |
| Kala Pharmaceuticals, Inc. | 1 | $23 |
| Lombart Brothers, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$3,174
- CEQUA$489
- OMNI(R) SURGICAL SYSTEM (US)$145
- PURIFIED CORTROPHIN GEL$125
- XIIDRA$120
- TYRVAYA$115
- VUITY$112
- TOTAL30$103
How this compares
$7,429 in reported general payments places this provider in the 95th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Kansas City
- Geoffrey PowellKansas City$55K
- Michael MooreKansas City$18K
- Kristen YatesKansas City$12K
- Crystal RemingtonKansas City$10K
- Kelsey KleinsasserKansas City$10K
- Lynn GastonKansas City$8K
- Andrew BiondoKirkwood$300K
- John McGrealSaint Louis$126K
- Alana KellerWildwood$94K
- Sarah HubbardChesterfield$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.